Exclusive interview and HNW content now available on Post Europe

post-europe-the-real-one

Post Europe’s weekly update is now live with an interview with Portuguese broker MDS and a View from The Top on how the Swedish market is embracing fine art.

Jose Manuel Dias da Fonseca, president of Portuguese broker MDS, talks to Post Europe about the Portuguese insurance market, regulation in the European Union and MDS's plans for expansion.

While Markel's Anne-Sofia Hedin explains why the rise of new, wealthier generation, with a renewed interest in fine art, not only as an investment but also as a fashion statement, has led Swedish insurers to reassure their high net worth offerings.

Post is dedicated to the European general insurance market and provides news, analysis, comment and features focused on different territories. To receive your personal update on all the recent European insurance new sign up for Post Europe Alerts.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

How brokering in Ukraine is triumphing over adversity

Interview: Ukrainian insurance broker Alina Golubieva talks to David Worsfold about the current challenges of insuring businesses and homes in the country, plus how the market is preparing to align itself with European Union regulation.

Diary of an Insurer: Consilium’s Roxy Zeb

Roxy Zeb, partner in Consilium’s professional and executive risks team, talks about getting back into the Lloyd’s and the London market after 10 years in Australia, her desire to inspire and drive greater diversity, as well as her love of property renovation.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here